Hepascore predicts liver outcomes and all‐cause mortality in long‐term methotrexate users: A retrospective cohort study

BACKGROUND AND AIM: Methotrexate (MTX) is routinely used for immunological disorders, and its long‐term use is associated with hepatotoxicity. The aim of this study was to investigate whether a serum liver fibrosis test (Hepascore) predicted the risk of adverse liver‐related outcomes and mortality....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhengyi, Huang, Yi, Nossent, Hans, Chan, Jonathan J, Adams, Leon A, Joseph, John, Cheng, Wendy, Garas, George, MacQuillan, Gerry, Jeffrey, Gary P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731826/
https://www.ncbi.nlm.nih.gov/pubmed/33319058
http://dx.doi.org/10.1002/jgh3.12430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731826/
https://www.ncbi.nlm.nih.gov/pubmed/33319058
http://dx.doi.org/10.1002/jgh3.12430

Ejemplares similares